RATINGS CHANGES

Chemours (CC - Get Report) was upgraded to overweight and assigned a $50 price target at JPMorgan. 

GW Pharmaceuticals (GWPH) was downgraded to sell at TheStreet Ratings. You can view the full analysis from the report here: GWPH.

Incyte (INCY - Get Report) was initiated with a market perform rating and assigned a $125 price target at Oppenheimer. 

Paycom Software (PAYC - Get Report) was initiated with an outperform rating and $75 price target at Wells Fargo. 

Toyota Motor TM was upgraded to buy at TheStreet Ratings. You can view the full analysis from the report here: TM.

Ultimate Software (ULTI - Get Report) was initiated with an outperform rating and $240 price target at Wells Fargo. 

Uni-Pixel (UNXL) was downgraded to neutral and assigned a $0.45 price target at Roth Capital. 

Visteon (VC - Get Report) was upgraded to overweight at Morgan Stanley and assigned a $115 price target. 

Westlake (WLK - Get Report) was upgraded to buy and assigned a $71 price target at Tudor Pickering. 

This article was written by a staff member of TheStreet.